News

On December 27, 2020, the President signed into law the “Consolidated Appropriations Act, 2021” (the “Act”). Included within this omnibus legislation are several provisions (in Division BB, Title III, Subtitle C) that affect the regulation of generic drugs and biosimilar medicines by the U.S.

Following our client alert published on November 17, 2020, it is informed that the Resolution that establishes the products whose import and exports is subject to regulation by the Ministry of Energy (the "Resolution") was published on December 26, 2020 and entered into effect on the 28th of the

As previously reported, USCIS has relaxed its rules regarding the in-person inspection of employee documents when filling out a Form I-9 in response to the COVID-19 pandemic. The agency recently announced that these “relaxed” rules have been extended until January 31, 2021.

In October 2020, the U.S. Supreme Court agreed to hear a case that could affect the viability of the Patent Trial and Appeal Board (PTAB) as well as countless PTAB patentability decisions — past, present and future....

A controversial proposed rule from the Financial Crimes Enforcement Network would bring bank-like regulation of virtual asset transactions, including the first broadly-applied AML reporting requirement in at least two decades.

The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company Arvelle Therapeutics for a total aggregate valuation of up to $960 million.

One of the provisions included in the Consolidated Appropriations Act that President Trump signed into law on December 27, 2020 addresses the so-called “felony streaming” loophole in the Copyright Act and criminal code.  Sponsored by Sen.

As the page is turned on 2020 and some hope exists with respect to a COVID-19 vaccine, Arizona finds itself with the dubious distinction of leading the nation in COVID-19 cases per 100,000.

Pages